Recent two-year advances in anti-dengue small-molecule inhibitors

Eur J Med Chem. 2022 Dec 5:243:114753. doi: 10.1016/j.ejmech.2022.114753. Epub 2022 Sep 22.

Abstract

Dengue is an acute tropical infectious disease transmitted by mosquitoes, which has posed a major challenge to global public health. Unfortunately, there is a lack of clinically proven dengue-specific drugs for its prevention and treatment. As the pathogenesis of dengue has not been fully elucidated, the development of specific drugs is seriously hindered. This article briefly describes the pathogenesis of dengue fever, the molecular characteristics, and epidemiology of dengue virus, and focuses on the potential small-molecule inhibitors of dengue virus, including on-target and multi-targeted inhibitors, which have been reported in the past two years.

Keywords: Aedes aegypti; Dengue fever; Flaviviruses; Inhibitors; Tropical diseases.

MeSH terms

  • Aedes*
  • Animals
  • Dengue Virus*